Correlation of the Serum Antithrombin III to Injury Severity in Patients with Severe Trauma.
- Author:
Ho Jin JI
1
;
Kang Hyun LEE
;
Sun Hyu KIM
;
Sung Bum OH
;
Kyung Chul CHA
;
Ho Jung KIM
;
Hyun KIM
;
Sung Oh HWANG
Author Information
1. Department of Emergency Medicine, Wonju College of Medicine, Yonsei University, Korea. ed119@wonju.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Trauma;
Antithrombin-III;
Disseminated intravascular coagulation;
Injury severity score
- MeSH:
Antithrombin III*;
APACHE;
Blood Coagulation;
Data Collection;
Disseminated Intravascular Coagulation;
Hemorrhage;
Humans;
Injury Severity Score;
Lactic Acid;
Logistic Models;
Mortality;
Multiple Trauma;
Prognosis;
Protease Inhibitors;
Retrospective Studies;
Sepsis;
Shock;
Systemic Inflammatory Response Syndrome;
Thrombin
- From:Journal of the Korean Society of Emergency Medicine
2004;15(5):399-405
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Antithrombin III (AT-III) is a serum protease inhibitor that inhibits the blood coagulation protease thrombin and is seen to be present in low levels in cases of shock, sepsis, or major trauma. Coagulopathy and hemorrhage are known contributors to trauma prognosis but the actual relationships of AT-III to mortality and to injury severity are unknown. The purpose of this study was to determine the correlation between AT-III and injury severity. METHODS: This study was a retrospective analysis of data collection from January 1, 2003, to December 31, 2003. Sixty patients with multiple trauma were studied. The revised trauma score (RTS), the injury severity score (ISS), the systemic inflammatory response syndrome score (SIRS), the acute physiology and chronic health evaluation III (APACHE III), the length of ICU stay, the base-deficit value and the serum lactate were measured to evaluate injury severity. We estimated the relation between the severity of injury and the serum level of AT-III. RESULTS: In patients with multiple trauma, the serum AT-III level was lower in the non-survival group (12.6 mg/dL) than it was in the survival group (17.2 mg/dL) (p=0.004). Among the previous injury severity evaluation system, the unit of transfusion for 24 hours had the strongest correlation with AT-III (R=0.546, p=0.000). The base deficit (R=0.418, p=0.001), the length of ICU stay (R=0.415, p=0,030), the APACHE III (R=0.367, p=0.021), and the RTS (R=0.247, p=0.006) were also correlated with AT-III. A logistic regression showed a strong association between the AT-III level and the mortality rate (mortality rate = 1.067- 0.370 x AT -III, p= 0.004). CONCLUSION: In patients with severe trauma, The serum AT-III level was correlated with the RTS, the APACHE III, the number of transfusion units, the severity of shock, and the length of ICU stay. The serum AT-III level also showed a strong correlation with mortality.
